Julian Baker’s Solid Biosciences SLDB Stock Holding History

Julian Baker’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-39,192	Closed	-$15.8M	–	98
2018 Q4	$15.8M	Hold	39,192	–	–	0.13%	39
2018 Q3	$27.7M	Hold	39,192	–	–	0.18%	34
2018 Q2	$20.9M	Hold	39,192	–	–	0.16%	41
2018 Q1	$4.41M	Buy	+39,192	New	+$13.2M	0.04%	79

Other funds holding SLDB

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Julian Baker's SLDB Position: Q1 2019 in Review

Julian Baker sold out of Solid Biosciences (SLDB) in Q1 2019, closing a stake of 39,192 shares — an estimated $15.8M sold.

Julian Baker first reported a position in SLDB in Q1 2018 and held it in 4 quarters. The position peaked at $27.7M in Q3 2018. 74 funds tracked by Wall St. Rank hold SLDB as of Q1 2019.

Julian Baker reported no remaining Solid Biosciences position as of Q1 2019 after selling out during the quarter.
Julian Baker sold 39,192 Solid Biosciences shares in Q1 2019, an estimated $15.8M.
Julian Baker first reported a position in Solid Biosciences in Q1 2018 and held it in 4 quarters.
Julian Baker's Solid Biosciences position peaked at $27.7M in Q3 2018.
74 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2019.

Based on Baker Bros. Advisors's 13F filing for Q1 2019, filed 15 May 2019.